# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-049860
Filing Date
2020-04-23
Accepted
2020-04-22 21:01:43
Documents
11
Period of Report
2020-06-09
Effectiveness Date
2020-04-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2016499d1_def14a.htm | DEF 14A | 321335
2 | GRAPHIC | tm2016499d1_def14a-img01.jpg | GRAPHIC | 8346
3 | GRAPHIC | tm2016499d1_def14a-img02.jpg | GRAPHIC | 2101
4 | GRAPHIC | tm2016499d1_def14a-img03.jpg | GRAPHIC | 2657
5 | GRAPHIC | tm2016499d1_def14a-img04.jpg | GRAPHIC | 3428
6 | GRAPHIC | tm2016499d1_def14a-img05.jpg | GRAPHIC | 877
7 | GRAPHIC | tm2016499d1_def14a-img06.jpg | GRAPHIC | 924
8 | GRAPHIC | tm2016499d1_def14a-img07.jpg | GRAPHIC | 2119
9 | GRAPHIC | tm2016499d1_def14a-img08.jpg | GRAPHIC | 2601
10 | GRAPHIC | tm2016499d1_def14a-img09.jpg | GRAPHIC | 476822
11 | GRAPHIC | tm2016499d1_def14a-img10.jpg | GRAPHIC | 280843
| Complete submission text file | 0001104659-20-049860.txt |  | 1399507

Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 20808998
SIC: 2834 Pharmaceutical Preparations